Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Phase III, multicentre, double–blind, placebo controlled, cross over study to evaluate the safety and efficacy of subcutaneous bioresorbable implants of afamelanotide in the treatment of solar urticaria (SU) https://www.kusajili.fr:443/Trial/0GGvAsxzyUe_97E005i-ZQ%24a-phase-iii-multicentre-double-blind-placebo-controlled-cross-over-study-to-evaluate-the-safety-and-efficacy-of-subcutaneous-bi
I have read and accept the terms of use of the site and the Privacy Policy
Send your message